Online citations, reference lists, and bibliographies.
← Back to Search

Recommandations Canadiennes Pour Les Pratiques Optimales De Prise En Charge De La Sclérose Latérale Amyotrophique

Christen Shoesmith, A. Abrahao, Tim Benstead, Marvin Chum, N. Dupré, Aaron Izenberg, W. Johnston, S. Kalra, D. Leddin, Colleen O’Connell, Kerri Schellenberg, Anu Tandon, Lorne Zinman
Published 2020 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
POINTS CLES La sclerose laterale amyotrophique (SLA) est une maladie progressive invalidante due a une degenerescence des motoneurones dans le cerveau et la moelle epiniere; elle provoque faiblesse, atrophie musculaire, fasciculations et spasticite[1][1]. La forme la plus frequente est
This paper references
10.7326/0003-4819-129-12-199812150-00041
The accuracy of substituted judgments in patients with terminal diagnoses.
D. Sulmasy (1998)
10.1080/14660820310002601
Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
R. Miller (2002)
10.1136/jnnp.74.9.1258
Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996–2000
B. Traynor (2003)
Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
R. Miller (2003)
Health Canada approves new drug to treat patients with amyotrophic lateral sclerosis (ALS)
(2004)
10.1080/14660820510028647
Promoting excellence in end‐of‐life care in ALS
H. Mitsumoto (2005)
10.1016/j.jns.2005.05.013
Discussing living wills. A qualitative study of a German sample of neurologists and ALS patients
N. Burchardi (2005)
10.1212/01.wnl.0000180717.29273.12
Multidisciplinary ALS care improves quality of life in patients with ALS
J. van den Berg (2005)
Outcome of sporadic amyotrophic lateral sclerosis treated with non-invasive ventilation and riluzole.
M. Sívori (2007)
10.1111/j.1468-1331.2006.01575.x
Riluzole and amyotrophic lateral sclerosis survival: a population‐based study in southern Italy
S. Zoccolella (2007)
10.1212/01.wnl.0000250444.30622.ee
Increased incidence of deep venous thrombosis in ALS
M. Qureshi (2007)
10.1111/j.1468-1331.2008.02123.x
Mononeuropathy multiplex as a result of treatment with interferon‐α and ribavirin in a patient with hepatitis C
C. Jacobi (2008)
10.1111/j.1468-1331.2007.02000.x
ALS patients and caregivers communication preferences and information seeking behaviour
A. Chiò (2008)
10.1017/S0317167100008507
A Recipe for ALS
C. Shoesmith (2008)
10.1212/WNL.0b013e3181bc01a4
Practice Parameter update: The care of the patient with amyotrophic lateral sclerosis: Multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review)
R. Miller (2009)
10.1002/mus.21213
Randomized double‐blind study of botulinum toxin type B for sialorrhea in als patients
C. Jackson (2009)
10.1590/S0004-282X2010000200021
Effect of nutritional supplementation with milk whey proteins in amyotrophic lateral sclerosis patients.
L. B. Silva (2010)
10.1212/WNL.0B013E3181D38CED
Practice Parameter update: The care of the patient with amyotrophic lateral sclerosis: Drug, nutritional, and respiratory therapies (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology
L. Wilkins (2010)
10.1212/WNL.0b013e318214359f
Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia
M. Elamin (2011)
Clinical practice guideline process manual
(2011)
10.1097/wco.0b013e328356d328
Amyotrophic lateral sclerosis.
A. Ludolph (2012)
10.1111/j.1468-1331.2011.03501.x
EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS) – revised report of an EFNS task force
P. Andersen (2012)
10.1177/0269216311399664
The Preferred Priorities for Care document in Motor Neurone Disease: Views of bereaved relatives and carers
H. Preston (2012)
The EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis
PM (2012)
10.3109/21678421.2013.823999
High-caloric food supplements in the treatment of amyotrophic lateral sclerosis: A prospective interventional study
J. Dorst (2013)
10.1007/s00415-013-7229-z
Live and let die: existential decision processes in a fatal disease
D. Lulé (2013)
10.3109/21678421.2013.763281
The impact of clinical factors, riluzole and therapeutic interventions on ALS survival: A population based study in Modena, Italy
E. Georgoulopoulou (2013)
10.1258/jhsrp.2012.011176
Patients’ experiences of health and social care in long-term neurological conditions in England: A cross-sectional survey
M. Peters (2013)
10.2188/jea.JE20120119
Riluzole and Prognostic Factors in Amyotrophic Lateral Sclerosis Long-term and Short-term Survival: A Population-Based Study of 1149 Cases in Taiwan
C. T. Lee (2013)
10.1371/journal.pone.0074733
Survival Analysis of Irish Amyotrophic Lateral Sclerosis Patients Diagnosed from 1995–2010
J. Rooney (2013)
10.1080/00222895.2014.891970
An Eye-Tracking Assistive Device Improves the Quality of Life for ALS Patients and Reduces the Caregivers’ Burden
Chi-shin Hwang (2014)
10.3109/21678421.2014.932385
Information needs and information-seeking preferences of ALS patients and their carers
S. Abdulla (2014)
10.1111/j.1369-7625.2012.00773.x
Dying with motor neurone disease, what can we learn from family caregivers?
R. Ray (2014)
10.1212/WNL.0000000000000405
Venous thromboembolism in amyotrophic lateral sclerosis
M. Gladman (2014)
10.1016/S0140-6736(14)60222-1
Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial
A. Wills (2014)
10.3109/21678421.2014.959024
Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients
K. Abe (2014)
10.3109/21678421.2014.911326
Evidence of an environmental effect on survival in ALS
N. Keren (2014)
10.1136/jnnp-2014-309601
A multidisciplinary clinic approach improves survival in ALS: a comparative study of ALS in Ireland and Northern Ireland
J. Rooney (2014)
Information needs and informationseeking preferences of ALS patients and their carers
S Abdulla (2014)
10.1007/s00415-015-7924-z
Strictly monitored exercise programs reduce motor deterioration in ALS: preliminary results of a randomized controlled trial
C. Lunetta (2015)
10.3109/21678421.2014.993650
The predictors of survival in Chinese amyotrophic lateral sclerosis patients
Q. Wei (2015)
10.1177/082585971503100304
Healthcare Needs of Patients with Amyotrophic Lateral Sclerosis (ALS) in Singapore: A patient-centred qualitative study from multiple perspectives
K. Ang (2015)
10.1044/2015_AJSLP-15-0010
"My World Has Expanded Even Though I'm Stuck at Home": Experiences of Individuals With Amyotrophic Lateral Sclerosis Who Use Augmentative and Alternative Communication and Social Media.
J. Caron (2015)
10.1701/1884.20552
[Guidelines 2.0: systematic development of a comprehensive checklist for a successful guideline enterprise].
G. P. Morgano (2015)
10.3109/21678421.2014.990036
Factors affecting longitudinal functional decline and survival in amyotrophic lateral sclerosis patients
Hazuki Watanabe (2015)
10.3109/21678421.2015.1051990
Impact of disease, cognitive and behavioural factors on caregiver outcome in amyotrophic lateral sclerosis
T. Watermeyer (2015)
10.1007/s00415-016-8313-y
Factors predicting survival in ALS: a multicenter Italian study
A. Calvo (2016)
10.3109/21678421.2016.1165256
Factors predicting survival in amyotrophic lateral sclerosis patients on non-invasive ventilation
Nuria González Calzada (2016)
10.1080/21678421.2016.1195410
Prognostic factors and survival of ALS patients from Belgrade, Serbia
Z. Stević (2016)
10.3389/fnagi.2016.00246
Long-Term Use of Riluzole Could Improve the Prognosis of Sporadic Amyotrophic Lateral Sclerosis Patients: A Real-World Cohort Study in China
Lu Chen (2016)
10.1177/0269216315613902
Advance care planning in motor neuron disease: A qualitative study of caregiver perspectives
L. Murray (2016)
10.1186/s12904-016-0097-4
Family caregivers’ accounts of caring for a family member with motor neurone disease in Norway: a qualitative study
S. Lerum (2016)
10.3109/21678421.2016.1143512
“I hate being a burden”: The patient perspective on carer burden in amyotrophic lateral sclerosis
Geraldine Foley (2016)
London (UK): National Institute for Healthcare and Excellence (NICE)
(2016)
10.1080/21678421.2017.1338298
Incorporation of telehealth into a multidisciplinary ALS Clinic: feasibility and acceptability
A. Geronimo (2017)
10.1016/S1474-4422(17)30115-1
Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial
Koji Abe (2017)
10.1080/21678421.2016.1267768
Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria
M. Strong (2017)
Amyotrophic lateral sclerosis — frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria. Amyotroph Lateral Scler Frontotemporal Degener 2017;18:153-74
MJ Strong (2017)
10.3389/fneur.2018.00442
Clinical Staging of Amyotrophic Lateral Sclerosis in Chinese Patients
Xueping Chen (2018)
10.1080/21678421.2017.1404108
A randomized controlled trial of resistance and endurance exercise in amyotrophic lateral sclerosis
L. Clawson (2018)
10.1016/S1474-4422(18)30054-1
Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging study
Ton Fang (2018)
10.1007/s00415-018-8770-6
Longitudinal predictors of caregiver burden in amyotrophic lateral sclerosis: a population-based cohort of patient–caregiver dyads
T. Burke (2018)
10.1007/s00415-018-8778-y
Riluzole and other prognostic factors in ALS: a population-based registry study in Italy
J. Mandrioli (2018)
10.1080/24745332.2018.1559644
Home mechanical ventilation for patients with Amyotrophic Lateral Sclerosis: A Canadian Thoracic Society clinical practice guideline
K. Rimmer (2019)
Treatment of pseudobulbar affect in ALS with dextromethorphan/quinidine: A randomized trial
V. Hingorani (2020)
A randomized controlled trial of resistance and endurance exercise in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 2018;19:250-8
LL Clawson (2020)
Centre des sciences de la santé Sunnybrook (Abrahao, Izenberg, Tandon, Zinman)
Affiliations
Kerri Schellenberg et Lorne Zinman ont été membres d'un comité consultatif scientifique sur Radicava (édaravone
Intérêts Concurrents Christen



Semantic Scholar Logo Some data provided by SemanticScholar